Up a level |
Ghofrani, Hossein-Ardeschir, Grimminger, Friedrich ORCID: 0000-0001-8725-6276, Gruenig, Ekkehard, Huang, Yigao, Jansa, Pavel ORCID: 0000-0002-3711-7064, Jing, Zhi-Cheng ORCID: 0000-0003-0493-0929, Kilpatrick, David, Langleben, David, Rosenkranz, Stephan, Menezes, Flavia, Fritsch, Arno, Nikkho, Sylvia and Humbert, Marc ORCID: 0000-0003-0703-2892 (2016). Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial. Lancet Resp. Med., 4 (5). S. 361 - 372. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600
Rosenkranz, Stephan, Ghofrani, Hossein-Ardeschir, Beghetti, Maurice, Ivy, Dunbar, Frey, Reiner, Fritsch, Arno, Weimann, Gerrit, Saleh, Soundos and Apitz, Christian (2015). Riociguat for pulmonary arterial hypertension associated with congenital heart disease. Heart, 101 (22). S. 1792 - 1800. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-201X